|
Volumn 47, Issue 1, 2008, Pages 155-156
|
Fatal tumor lysis syndrome after irinotecan/5-FU/folinic acid/bevacizumab-containing therapy in a patient heavily pretreated for metastatic colon cancer [4]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BEVACIZUMAB;
BISPHOSPHONIC ACID DERIVATIVE;
CAPECITABINE;
EPIDERMAL GROWTH FACTOR;
FLUOROURACIL;
FOLINIC ACID;
IRINOTECAN;
OXALIPLATIN;
BONE METASTASIS;
CANCER CHEMOTHERAPY;
CANCER PATIENT;
CANCER SURGERY;
COLON CANCER;
DIARRHEA;
HUMAN;
LETTER;
LUNG DISEASE;
LUNG METASTASIS;
METASTASIS;
MULTIPLE CYCLE TREATMENT;
PRIORITY JOURNAL;
THYROID DISEASE;
TUMOR LYSIS SYNDROME;
TUMOR VOLUME;
ANTIBODIES, MONOCLONAL;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CAMPTOTHECIN;
COLORECTAL NEOPLASMS;
FATAL OUTCOME;
FLUOROURACIL;
HUMANS;
LEUCOVORIN;
LUNG NEOPLASMS;
MALE;
MIDDLE AGED;
TUMOR LYSIS SYNDROME;
|
EID: 37549024644
PISSN: 0284186X
EISSN: 1651226X
Source Type: Journal
DOI: 10.1080/02841860701460533 Document Type: Letter |
Times cited : (14)
|
References (6)
|